Altered microRNA expression patterns in hepatoblastoma patients

Translational Oncology

Volumn 2, Issue 3, 2009, Pages 157-163

  Magrelli, Armando ^a   Azzalin, Gianluca ^b   Salvatore, Marco ^a   Viganotti, Mara ^a   Tosto, Fabrizio ^a   Colombo, Teresa ^b   Devito, Rita ^c   Di Masi, Alessandra ^d   Antoccia, Antonio ^d   Lorenzetti, Stefano ^a   Maranghi, Francesca ^a   Mantovani, Alberto ^a   Tanzarella, Caterina ^d   Macino, Giuseppe ^b   Taruscio, Domenica ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d ROMA TRE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BETA CATENIN; MICRORNA; SOMATOMEDIN B; TUMOR MARKER;

ADOLESCENT; ADULT; ARTICLE; CANCER CLASSIFICATION; CARCINOGENESIS; CHILD; CLINICAL ARTICLE; FEMALE; GENE CONTROL; GENE EXPRESSION; HEPATOBLASTOMA; HUMAN; HUMAN TISSUE; INCIDENCE; LIVER CELL CARCINOMA; MALE; METHYLATION; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

EID: 77953366673     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.09124     Document Type: Article

References (47)

1. Roebuck DJ and Perilongo G (2006). Hepatoblastoma: an oncological review. Pediatr Radiol 36, 183-186.
2. McLaughlin CC, Baptiste MS, Schymura MJ, Nasca PC, and Zdeb MS (2006). Maternal and infant birth characteristics and hepatoblastoma. Am J Epidemiol 163, 818-828.
3. Reynolds P, Urayama KY, Von Behren J, and Feusner J (2004). Birth characteristics and HB risk in young children. Cancer 100, 1070-1076. (Pubitemid 38222868)
4. Suzuki M, Kato M, Yuyan C, Takita J, Sanada M, Nannya Y, Yamamoto G, Takahashi A, Ikeda H, Kuwano H, et al. (2008). Whole-genome profiling of chromosomal aberrations in hepatoblastoma using high-density single-nucleotide polymorphism genotyping microarrays. Cancer Sci 99, 564-570. (Pubitemid 351228574)
5. Nagata T, Nakamura M, Shichino H, Chin M, Sugito K, Ikeda T, Koshinaga T, Fukuzawa M, Inoue M, and Mugishima H (2005). Cytogenetic abnormalities in HB: report of two new cases and review of the literature suggesting imbalance of chromosomal regions on chromosomes 1, 4, and 12. Cancer Genet Cytogenet 156, 8-13.
6. Steenman M, Westerveld A, and Mannens M (2000). Genetics of Beckwith-Wiedemann syndrome-associated tumors: common genetic pathways. Genes Chromosomes Cancer 28, 1-13. (Pubitemid 30176757)
7. Hu M, Kurobe M, Jeong YJ, Fuerer C, Ghole S, Nusse R, and Sylvester KG (2007). Wnt/signalling in murine hepatic transit amplifying progenitor cells. Gastroenterology 133, 1579-1591. (Pubitemid 350029747)
8. Sangkhathat S, Kusafuka T, Miao J, Yoneda A, Nara K, Yamamoto S, Kaneda Y, and Fukuzawa M (2006). In vitro RNA interference against beta-catenin inhibits the proliferation of pediatric hepatic tumors. Int J Oncol 28, 715-722.
9. Mulholland DJ, Dedhar S, Coetzee GA, and Nelson CC (2005). Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocr Rev 26, 898-915.
10. Koesters R and von Knebel Doeberitz M (2003). The Wnt signaling pathway in solid childhood tumors. Cancer Lett 198, 123-138. (Pubitemid 37297785)
11. Li X, Gray SG, Flam F, Pietsch T, and Ekström TJ (1998). Developmental-dependent DNA methylation of the IGF2 and H19 promoters is correlated to the promoter activities in human liver development. Int J Dev Biol 42, 687-693. (Pubitemid 28341947)
12. Tang SH, Yang DH, Huang W, Zhou HK, Lu XH, and Ye G (2006). Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population. Clin Cancer Res 15, 4171-4177.
13. Gray SG, Eriksson T, Ekstrom C, Holm S, von Schweinitz D, Kogner P, Sandstedt B, Pietsch Tand Ekstöm1 TJ (2000). Altered expression of members of the IGF-axis in hepatoblastomas. Br J Cancer 82, 1561-1567. (Pubitemid 30204363)
14. Dalmay T (2008). MicroRNAs and cancer. J Intern Med 263, 366-375.
15. Abbott AL, Alvarez-Saavedra E, Miska EA, Lau NC, Bartel DP, Horvitz HR and Ambros V (2005). The let-7 MicroRNA family members mir-48, mir-84, and mir-241 function together to regulate developmental timing in Caenorhabditis elegans. Dev Cell 9, 403-414. (Pubitemid 41235809)
16. Lee CT, Risom T, and Strauss WM (2006). MicroRNAs in mammalian development. Birth Defects Res C Embryo Today 78, 129-139.
17. Chen CZ, Li L, Lodish HF, and Bartel DP (2004). MicroRNAs modulate hematopoietic lineage differentiation. Science 303, 83-86. (Pubitemid 38055775)
18. Lee RC and Ambros V (2001). An extensive class of small RNAs in Caenorhabditis elegans. Science 294, 862-864.
19. Lau NC, Lim LP, Weinstein EG, and Bartel DP (2001). An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294, 858-862.
20. Lagos-Quintana M, Rauhut R, Lendeckel W, and Tuschl T (2001). Identification of novel genes coding for small expressed RNAs. Science 294, 853-858. (Pubitemid 33032103)
21. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435, 834-838. (Pubitemid 40839735)
22. Calin GA and Croce CM (2006). MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 66, 7390-7394.
23. Esquela-Kerscher A and Slack FJ (2006). Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6, 259-269.
24. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, Taccioli C, Zanesi N, Garzon R, Aqeilan RI, et al. (2008). MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci USA 105, 5166-5171. (Pubitemid 351738528)
25. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et al. (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9, 189-198. (Pubitemid 43357945)
26. Akao Y, Nakagawa Y, and Naoe T (2007). MicroRNA-143 and -145 in colon cancer. DNA Cell Biol 26, 311-320.
27. Akao Y, Nakagawa Y, and Naoe T (2006). MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol Rep 16, 845-850.
28. Bandres E, Cubedo E, Agirre X, Malumbres R, Zárate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzó M, et al. (2006). Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5, 29. (Pubitemid 44264064)
29. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65, 7065-7070. (Pubitemid 41161233)
30. Chan JA, Krichevsky AM, and Kosik KS (2005). MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65, 6029-6033. (Pubitemid 40994386)
31. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, and Patel T (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133, 647-658. (Pubitemid 47187346)
32. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, et al. (2008). MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68, 425-433.
33. Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, Ciafrè SA, and Farace MG (2007). miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 282, 23716-23724. (Pubitemid 47311902)
34. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y and Takahashi T (2005). A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65, 9628-9632. (Pubitemid 41541436)
35. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E, Grazi GL, et al. (2007). Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 67, 6092-6099. (Pubitemid 47037488)
36. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, and Shimotohno K (2006). Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25, 2537-2545.
37. Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM, et al. (2008). Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 47, 897-907.
38. Varnholt H (2008). The role of microRNAs in primary liver cancer. Ann Hepatol 7 (2), 104-113. (Pubitemid 351845519)
39. Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, Roberts LR and Schmittgen TD (2008). Association of microRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 14, 419-427. (Pubitemid 351226109)
40. Huang YS, Dai Y, Yu XF, Bao SY, Yin YB, Tang M, and Hu CX (2008). Microarray analysis of microRNA expression in hepatocellular carcinoma and nontumorous tissues without viral hepatitis. J Gastroenterol Hepatol 23, 87-94. (Pubitemid 350265207)
41. Honda S, Arai Y, Haruta M, Sasaki F,Ohira M, Yamaoka H, Horie H, Nakagawara A, Hiyama E, Todo S, et al. (2008). Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma. Br J Cancer 99, 1891-1899.
42. Koch A, Denkhaus D, Albrecht S, Leuschner I, von Schweinitz D, and Pietsch T (1999). Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the β-catenin gene. Cancer Res 59, 269-273. (Pubitemid 29048850)
43. Beeghly AC, Katsaros D, Wiley AL, Rigault de la Longrais IA, Prescott AT, Chen H, Puopolo M, Rutherford TJ and Yu H (2007). IGF-II promoter methylation and ovarian cancer prognosis. J Cancer Res Clin Oncol 133, 713-723. (Pubitemid 47319238)
44. Gautier L, Cope L, Bolstad BM, and Irizarry RA (2004). affy - analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307-315. (Pubitemid 38262761)
45. Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou L, and Zucman-Rossi J (2008). MicroRNA profiling in hepatocellular tumors is associated to clinical features an oncogene tumor suppressor gene mutations. Hepatology 47 (6), 1955-1963. (Pubitemid 351952843)
46. Wang Y, Lee AT, Ma JZ, Wang J, Ren J, Yang Y, Tantoso E, Li KB, Ooi LL, Tan P, et al. (2008). Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J Biol Chem 283 (19), 13205-13215.
47. Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W, Jacob ST, and Ghoshal K (2006). Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 99, 671-678. (Pubitemid 44521987)